Bronchitis
📧 Sign up to get email alerts when something new happens for Bronchitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis [Phase 4]
Phase 4 trial evaluating losartan for airway mucociliary dysfunction in COPD and chronic bronchitis was terminated with results posted.
-
FDA approval · 2020-03-09FDA Approved: CEFDINIR — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for CEFDINIR (cefdinir) from Aurobindo Pharma Limited, a generic cephalosporin antibiotic.
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of 'DW1601' in Acute Bronchitis [Phase 3]
A Phase 3 clinical trial update for DW1601 evaluating efficacy and safety in acute bronchitis; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase) [Phase 4]
Phase 4 trial evaluating the efficacy and safety of MUCOLASE Tablet (Streptokinase • Streptodornase) for acute upper respiratory infection a…
-
FDA approval · 2020-01-23FDA Approved: AZITHROMYCIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for azithromycin filed by Aurobindo Pharma Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-12-19FDA Approved: CEFUROXIME AXETIL — Supplemental Application (Golden State Medical Supply, Inc.)
FDA approved a supplemental application for cefuroxime axetil from Golden State Medical Supply, Inc., recognizing an update to this generic …
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: Study of Gefapixant (MK-7264) in Acute Cough for Participants With Induced Viral Upper Respiratory Tract Infection (URTI) (MK-7264-013) [Phase 2]
A Phase 2 clinical trial of gefapixant (MK-7264) for acute cough due to induced viral URTI was terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Leukocyte Function in Chronic Obstructive Pulmonary Disease (COPD)
A completed clinical trial updated results on leukocyte function in patients with COPD and emphysema, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Regulation of the Release of Inflammatory Mediators From Lung Macrophages.
Clinical trial studying regulation of inflammatory mediator release from lung macrophages in COPD and related conditions; completed with res…
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Macrophage Phagocytosis in COPD
A completed clinical trial from Imperial College London investigating macrophage phagocytosis in COPD with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-11Clinical Trial Update: Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections [Phase 3]
Phase 3 trial evaluating acceptance of clarithromycin formulated as a straw versus syrup in children with upper respiratory tract infections…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis [Phase 2]
Phase 2 clinical trial update evaluating GHX02 for acute bronchitis, focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Umkamin Tab in Acute Bronchitis Patients [Phase 3]
Phase 3 trial comparing HL301 to Umkamin Tab in acute bronchitis has completed.
-
CLINICAL_TRIALS research · 2019-02-08Clinical Trial Update: Clinical Trials to Assess the Efficacy and Safety of HLIM [Phase 3]
A Phase 3 clinical trial update for HLIM evaluating efficacy and safety in acute upper respiratory tract infection and acute bronchitis; the…
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema) [Phase 3]
GlaxoSmithKline's investigational drug GW815SF for chronic obstructive pulmonary disease (including chronic bronchitis and emphysema) comple…
-
CLINICAL_TRIALS withdrawal · 2019-01-31Clinical Trial Update: A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects [Phase 2]
Pfizer's Phase 2 study of PF-00610355 in moderately asthmatic subjects has been withdrawn.
-
CLINICAL_TRIALS safety_alert · 2019-01-29Clinical Trial Update: Fluoroquinolone Associated Disability
Update on safety concerns related to fluoroquinolone antibiotics and the potential risk of disability, affecting patients treated for bronch…
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: Phase III Study to Evaluate the Efficacy and Safety of HOB-048 CR Tab. in Comparison With HOB-048 Syrup in Patients With Cough Due to Acute or Chronic Bronchitis [Phase 3]
Phase 3 study evaluating efficacy and safety of HOB-048 CR tablets versus HOB-048 syrup for cough associated with acute or chronic bronchiti…
-
CLINICAL_TRIALS trial_result · 2018-10-19Clinical Trial Update: Airway Clearance for Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation [Phase 4]
Phase 4 clinical trial updates airway clearance for COPD prevention; study completed with posted results.
-
FDA approval · 2018-10-03FDA Approved: ROFLUMILAST — Original Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved Jubilant Cadista's original application for roflumilast, a PDE-4 inhibitor, to reduce the risk of COPD exacerbations in adults …
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Study Regarding the Clinical Efficacy of Synatura® in Patients With Chronic Bronchitis Type COPD [Phase 4]
Phase 4 trial update evaluating the clinical efficacy of Synatura® in patients with chronic bronchitis-type COPD has been completed.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Postoperative Rehabilitation After Cardiac Surgery in Patients at Risk of Respiratory Complications. Effects of a Continuous Bi-laterosternal Infusion of Ropivacaine Through Multihole Catheters [Phase 2]
Phase 2 trial evaluating continuous bilateral sternum ropivacaine infusion via multihole catheters to aid postoperative rehabilitation in ca…
-
CLINICAL_TRIALS research · 2018-05-07Clinical Trial Update: The Development and Testing of a Scaling Strategy for a Community-Based Primary Care Antimicrobial Stewardship Program [NA]
A clinical trial update describing development and testing of a scaling strategy for a community-based antimicrobial stewardship program in …
-
CLINICAL_TRIALS withdrawal · 2018-03-07Clinical Trial Update: A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions [Phase 1]
A Phase 1 bioequivalence study comparing SKF101804 cefixime to a cefixime reference formulation in healthy adults under fasting conditions h…
-
FDA approval · 2018-03-05FDA Approved: MUCUS DM — Original Application (HyVee Inc)
FDA approved HyVee Inc's MUCUS DM as an original-application generic product containing dextromethorphan hydrobromide and guaifenesin for te…